AbbVie | ABBV - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 2.94M 2026-03
ALKERMES USD 166.46M 855K 2026-03
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eisai JPY 282.11M 0 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 1.38M 2025-12
Merck USD 2.47B 12.72M 2025-12
Neurocrine Biosciences USD 100.6M 500K 2026-03
Novartis USD 1.91B 60K 2026-03
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 13M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03
Zoetis USD 420.35M 4.58M 2026-03